Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nautilus Biotechnology Inc NAUT

Healthcare Advertising Agencies Biotechnology
Nautilus Biotechnology, Inc. is a development stage life sciences company. The Company is engaged in creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company is focused on transforming the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. The Company's platform... see more

Recent & Breaking News (NDAQ:NAUT)

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research's Distinguished Investigator Award

GlobeNewswire October 31, 2024

Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference

GlobeNewswire October 30, 2024

Nautilus Biotechnology Reports Third Quarter 2024 Financial Results

GlobeNewswire October 29, 2024

Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024

GlobeNewswire October 8, 2024

Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer

GlobeNewswire September 17, 2024

Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

GlobeNewswire August 14, 2024

Nautilus Biotechnology Reports Second Quarter 2024 Financial Results

GlobeNewswire July 30, 2024

Kaskela Law LLC Announces Investigation of Nautilus Biotechnology, Inc. (NAUT) and Encourages Former Nautilus Employees to Contact the Firm

Newsfile July 15, 2024

Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024

GlobeNewswire July 9, 2024

Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

GlobeNewswire May 23, 2024

Nautilus Biotechnology Reports First Quarter 2024 Financial Results

GlobeNewswire April 30, 2024

Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024

GlobeNewswire April 11, 2024

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results

GlobeNewswire February 28, 2024

Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference

GlobeNewswire February 22, 2024

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

GlobeNewswire February 7, 2024

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award

GlobeNewswire November 30, 2023

Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development

GlobeNewswire November 1, 2023

Nautilus Biotechnology Reports Third Quarter 2023 Financial Results

GlobeNewswire October 31, 2023

Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023

GlobeNewswire October 11, 2023

Nautilus Biotechnology to Participate in Upcoming September Investor Conferences

GlobeNewswire September 6, 2023